Avascular necrosis of the femoral head in sickle cell disease patients

Ortopedia Traumatologia Rehabilitacja

Volumn 14, Issue 2, 2012, Pages 155-159

  Matos, Marcos Almeida ^a,b   dos Santos Silva, Luanne Lisle ^b   Fernandes, Rony Brito ^b   Malheiros, Cristiane Dias ^a   da Silva, Bruno Vieira Pinto ^b  

^a Bahian School of Medicine and Public Health   (Poland)

^b Pediatric Orthopedic Service of Santa Izabel Hospital   (Poland)

Author keywords

Avascular necrosis; Femoral head; Sickle cell disease

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; COMORBIDITY; CROSS-SECTIONAL STUDY; FEMALE; FEMUR HEAD NECROSIS; HUMAN; MALE; PREVALENCE; RISK FACTOR; SICKLE CELL ANEMIA;

ADOLESCENT; AGE FACTORS; ANEMIA, SICKLE CELL; CHILD; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; FEMUR HEAD NECROSIS; HUMANS; MALE; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84861642669     PISSN: 15093492     EISSN: None     Source Type: Journal    
DOI: 10.5604/15093492.992286     Document Type: Article

References (19)

1. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ.2001; 79:704-12.
2. Zago MA, Costa EF. Hereditary hemoglobin disorders in Brazil. Trans R Soc Trop Med Hyg. 1985; 79:385-8.
3. Silla, L. Doença falciforme: um grave e desconhecido problema de saúde pública no Brasil. J Pediatr (Rio). 1999; 75:145-6.
4. Adams R, McKie V, Nichols F, Carl E, Zhang DL, McKie K, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992; 326:605-10.
5. Salzano FM, Tondo CV. Incidence, effects and management of sickle cell disease in Brazil. Am J Pediatr Hematol Oncol.1985; 7:240-44.
6. Chambers JB, Forsythe DW, Bertrand SL, Iwinski HJ, Steflik DE. Retrospective review of osteoarticular infections in a pediatric sickle cell age group. J Pediat Orthop. 2000; 20:682-5.
7. Diggs LW. Bone and joint lesion in sickle cell patients. Clin Orthop. 1967; 53:119-21.
8. Aguilar C, Vichinsky E, Neumayr L. Bone and joint disease in sickle cell disease. Henatol Oncol Clin North Am. 2005; 19:929-41.
9. Al-Mousawi FR, Malki AA. Managing femoral head osteonecrosis in patients with sickle cell disease. J Royal Coll Surg Edinburgh & Ireland. 2007; 5:282-89.
10. Milner PF, Kraus AP, Sebes JI, Sleeper LA, Dukes KA, Embury SH, et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med. 1991; 325:1476-81.
11. Hernigou P, Bachir D, Galacteros F. The natural history of symptomatic osteonecrosis in adults with sickle-cell disease. J Bone Joint Surg Am. 2003; 85:500-504.
12. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, et al. Pain in sickle cell disease: rates and risk factors. N Engl J Med. 1991; 325:11-6.
13. Charnley J. The long term results of low friction arthroplaty of the hip performed as a primary intervention. J Bone Joint Surg Br. 1972;54:61-76.
14. Catterall A. The natural history of Perthe's disease. J Bone Joint Surg Br. 1971; 53:37-53.
15. Ficat, RP. Idiopathic bone necrosis of the femoral head. J Bone Joint Surg Br. 1985; 67:3-9.
16. Gallo HA, Cursino MB. Anemia Falciforme: Estudo de 98 casos. Rev Inst Est Hem. 1992; 9:5-11.
17. Milner PF, Kraus AP, Sebes JI, Sleeper LA, Dukes KA, Embury SH, et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med. 1991; 325:1476-81.
18. Beers EJV, Schaap MCL, Berckmans RJ, Nieuwland R, Sturk A, Doormaal FFV, Meijers JCM, Biemond BJ. Circulating erythrocyte- derived microparticles are associated with coagulation activation in sickle cell disease. Heamatologica.2009;94:1513-1519.
19. Akinyoola AL, Adediran LA, Asaleye CM, Bolarinwa AR. Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease. Int Orthop, 2009;33:932-926.